Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2003
12/03/2003EP1366148A2 Differentiation of stem cells to pancreatic endocrine cells
12/03/2003EP1366144A2 A device for preparing cells
12/03/2003EP1366079A2 Nuclear hormone receptor ligand binding domain
12/03/2003EP1365842A2 Inflammatory cytokine secretion inhibition
12/03/2003EP1365800A2 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/03/2003EP1365790A2 Diagnostic indicator of thymic function
12/03/2003EP1365784A1 Methods and devices for tissue repair
12/03/2003EP1365783A1 Myb-transformed blood cells and their use for active ingredient screening
12/03/2003EP1365778A2 Treating pulmonary disorders with gaseous agent causing repletion of gsno
12/03/2003EP1365769A1 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
12/03/2003EP1365760A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
12/03/2003EP1246634B1 Neurotoxins for treating pancreatic disorders
12/03/2003EP0980270B1 Dermal sheath tissue in wound healing
12/03/2003EP0901405B1 Fibrinogen apparatus, method and container
12/03/2003EP0859830B1 Growth of adult pancreatic islet cells with laminin 5
12/03/2003EP0744892B1 Anticoagulant compositions for platelets
12/03/2003CN1459312A Traditional Chinese medicine for treating deformed soft-tissue
12/03/2003CN1459310A Medicine for treating osteoproliferation
12/03/2003CN1459295A Traditional Chinese medicinal powder pasted on shenchueh acupoint for treating astriction
12/03/2003CN1459286A Tetrodotoxin respiratory tract administration prepn. used for giving-up drug and easing pain
12/03/2003CN1129667C Autoimmune cell for treating tumor and its preparing process
12/03/2003CN1129453C Mycobacterium vaccae for down regulation of Th2 activity of immune system
12/03/2003CN1129451C Process for preparing injection liquid of brain protein hydrolyzate
12/03/2003CN1129449C Pain treatnig composite medicine
12/03/2003CN1129448C Chinese medicine pills for treating cataract
12/03/2003CN1129445C Burn treating Chinese medicine prepn.
12/03/2003CN1129444C Antiabortifacient for treating acyesis and sterility and its preparing process
12/03/2003CN1129443C Medicine for treating impotence
12/03/2003CN1129440C Preparing process for piles treating medicine
12/03/2003CN1129439C Hyperosteogeny treating capsule
12/03/2003CN1129438C Bone strengthening and pus drawing out ointment
12/03/2003CN1129437C Decoction of medicinal ingredients for curing enterogastric diseases
12/03/2003CN1129436C Oral care composition comprising bacillus pullulanase and dextranase
12/03/2003CN1129434C Heart disease treating jade
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/02/2003US6656961 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
12/02/2003US6656918 Contacting the ductal epithelium of the exocrine gland with epithelium destroying agents such as ethanol and vaccinia virus
12/02/2003US6656480 Nucleotide sequences which code polypeptide for use the treatment of mammary gland cancer
12/02/2003US6656479 Protects a mammal against neosporosis
12/02/2003US6656463 Administering 5 Felix 0-1 Phage (F01 phage) in acceptable carrier to a livestock animal to reduce or prevent dissemination of Salmonella
12/02/2003CA2161804C Purification of plasma proteins
11/2003
11/27/2003WO2003097871A2 Marker molecules associated with lung tumors
11/27/2003WO2003097846A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003WO2003097845A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
11/27/2003WO2003097809A2 Sterilized xenograft tissue
11/27/2003WO2003097799A2 HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS
11/27/2003WO2003097091A2 Glucan-based vaccines
11/27/2003WO2003097081A1 Composition for treating or preventing hyperuricemia
11/27/2003WO2003097075A1 Blood treatment
11/27/2003WO2003097052A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/27/2003WO2003096972A2 Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
11/27/2003WO2003078568A3 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
11/27/2003WO2003068172A3 Undesignated allogeneic stem cell bank
11/27/2003WO2003055513A3 Bacillus subtilis spores to stimulate the immune responses
11/27/2003WO2003035883A3 Methods and compositions for inducing tumor-specific cytotoxicity
11/27/2003WO2003011445A3 Photolytic cell for providing physiological gas exchange
11/27/2003WO2003001981A3 Method of promoting engraftment of a donor transplant in a recipient host
11/27/2003WO2002089737A3 Separation of platelets from whole blood for use as a healant
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002072632A3 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
11/27/2003WO2002070006A8 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/27/2003WO2000062735A3 Treatment of neoplasms with viruses
11/27/2003US20030221199 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/27/2003US20030220692 Preparations of nucleus pulposus cells and methods for their generation, identification, and use
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
11/27/2003US20030220362 Novel inhibitors of formation of advanced glycation endproducts (AGEs)
11/27/2003US20030220280 Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate CNS nerve regeneration
11/27/2003US20030220247 Enhanced gamma-carboxylation of recombinant vitamin K-dependent clotting factors
11/27/2003US20030220244 Contacting a culture of an adult stem cells with a hedgehog polypeptide to promote the growth and differentiation of a three dimensional cartilage matrix in the culture cells, isolating and transplanting the cartilage matrix to a patient
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030219898 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219866 Culturing pluripotent cells and monitoring expression of transcriptional marker protein (OCT4); animal models for cell differentiation; veterinary medicine
11/27/2003US20030219789 36P6D5: secreted tumor antigen
11/27/2003US20030219475 Preservation of bioactive materials by freeze dried foam
11/27/2003US20030219465 Composition for delivery of dithranol
11/27/2003US20030219463 Comprises cytotoxic lymphocytes which express CD3-antigen; cytokines
11/27/2003US20030219423 Methods of inducing or enhancing connective tissue repair
11/27/2003US20030219420 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
11/27/2003US20030219419 Alteration of cell membrane for new functions
11/27/2003US20030219418 Diabetic treatment by regenerating pancreas cells, genetic engineered animal embryonic pancreatic cells from different species, inserting embryonic cells into the kidney capsule of non-obese diabetic/ severe combined immunodeficiency animal
11/27/2003US20030219412 Somatic gene therapy to suppress secondary cataract formation following eye surgery
11/27/2003US20030219376 Progression elevated Gene-3 and uses thereof
11/27/2003US20030219354 Deactivation pathogens; using riboflavin sensitizers; exposure to light source
11/27/2003CA2830619A1 Glucan-based vaccines
11/27/2003CA2812019A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2794297A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione for treatment and management of amyloidosis
11/27/2003CA2794060A1 Methods and compositions using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione for treatment and management of multiple myeloma
11/27/2003CA2752140A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-1-yl)-piperidine-2,6-dione for treatment and management of renal cancer
11/27/2003CA2752127A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of hepatocellular carcinoma
11/27/2003CA2752124A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of head and neck cancer
11/27/2003CA2752122A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of ovarian cancer
11/27/2003CA2727830A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma
11/27/2003CA2727824A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of solid tumors
11/27/2003CA2525645A1 Sterilized xenograft tissue
11/27/2003CA2486583A1 Marker molecules associated with lung tumors
11/27/2003CA2486327A1 Htlv-i tax induced killing of p53 null cancer cells
11/27/2003CA2486313A1 Composition for treating or preventing hyperuricemia
1 ... 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 ... 1259